文献速递哮喘

英国哮喘管理不充分相关温室气体排放:SABINA CARBON研究

Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
PubMed 文献 · Thorax · 2024-02-27

该回顾性队列研究基于英国CPRD数据库(2008—2019年)纳入236 506例≥12岁现患哮喘患者,按基线控制状态分为良好控制与不佳控制,估算哮喘相关用药、医疗资源使用和急性发作产生的温室气体排放(以CO2e计)。结果显示47.3%患者基线控制不佳,英国哮喘诊疗总体碳足迹为750 540吨CO2e/年,其中控制不佳所致超额排放为303 874吨CO2e/年。

要点

  • 控制不佳哮喘人均碳足迹为良好控制的3.1倍,超额部分达8.1倍,主要来自SABA使用。
  • 英国哮喘诊疗年碳足迹750 540吨CO2e,控制不佳贡献超额排放303 874吨CO2e/年。
  • 减少高SABA使用和急性发作或可显著降低哮喘诊疗相关碳排放。

核心结论

  • 控制不佳哮喘带来显著超额温室气体排放,改善哮喘控制包括减少高SABA使用可能大幅降低哮喘诊疗相关碳排放。

研究设计与样本

  • 回顾性队列研究,基于英国临床实践研究数据链(CPRD)2008—2019年数据,纳入236 506例≥12岁现患哮喘患者,按基线控制状态分组并估算CO2e排放。

主要发现

  • 47.3%患者基线哮喘控制不佳。
  • 英国哮喘诊疗总体碳足迹为750 540吨CO2e/年,控制不佳相关超额排放为303 874吨CO2e/年,相当于英国逾124 000户住宅的排放量。
  • 控制不佳较良好控制哮喘总体人均碳足迹高3.1倍、超额人均碳足迹高8.1倍,主要来自SABA,医疗资源使用贡献较小。

关键数值与推荐

  • 良好控制定义为<3支短效β2受体激动剂(SABA)罐/年且无急性发作;控制不佳定义为≥3支SABA罐/年或≥1次急性发作。
  • 超额排放计算涵盖≥3支SABA罐/年处方、急性发作及住院或急诊就诊后10天内任何全科医生和门诊就诊。

临床怎么用

  • 呼吸科智能体应识别高SABA使用和反复急性发作的控制不佳哮喘患者,将其作为改善控制与降低碳足迹的重点管理对象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poorly controlled asthma is associated with increased morbidity and healthcare resource utilisation (HCRU). Therefore, to quantify the environmental impact of asthma care, this retrospective, cohort, healthCARe-Based envirONmental cost of treatment (CARBON) study estimated greenhouse gas (GHG) emissions in the UK associated with the management of well-controlled versus poorly controlled asthma. METHODS: Patients with current asthma (aged ≥12 years) registered with the Clinical Practice Research Datalink (2008‒2019) were included. GHG emissions, measured as carbon dioxide equivalent (CO2e), were estimated for asthma-related medication use, HCRU and exacerbations during follow-up of patients with asthma classified at baseline as well-controlled (<3 short-acting β2-agonist (SABA) canisters/year and no exacerbations) or poorly controlled (≥3 SABA canisters/year or ≥1 exacerbation). Excess GHG emissions due to suboptimal asthma control included ≥3 SABA canister prescriptions/year, exacerbations and any general practitioner and outpatient visits within 10 days of hospitalisation or an emergency department visit. RESULTS: Of the 236 506 patients analysed, 47.3% had poorly controlled asthma at baseline. Scaled to the national level, the overall carbon footprint of asthma care in the UK was 750 540 tonnes CO2e/year, with poorly controlled asthma contributing excess GHG emissions of 303 874 tonnes CO2e/year, which is equivalent to emissions from >124 000 houses in the UK. Poorly controlled versus well-controlled asthma generated 3.1-fold higher overall and 8.1-fold higher excess per capita carbon footprint, largely SABA-induced, with smaller contributions from HCRU. CONCLUSIONS: These findings suggest that addressing the high burden of poorly controlled asthma, including curbing high SABA use and its associated risk of exacerbations, may significantly alleviate asthma care-related carbon emissions.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Wilkinson, Maslova, Janson, et al. Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study. Thorax. 2024. PMID: 38413192. doi:10.1136/thorax-2023-220259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。